PROCEPT BioRobotics Corporation Deferred Revenue Recognized
PROCEPT BioRobotics Corporation (PRCT) reported Deferred Revenue Recognized of $5.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-05
- PROCEPT BioRobotics Corporation contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $5.70M, a 137.50% increase year-over-year.
- PROCEPT BioRobotics Corporation contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $5.20M, a 30.00% increase year-over-year.
- PROCEPT BioRobotics Corporation contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $2.40M.
- PROCEPT BioRobotics Corporation contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $4.00M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month |
|---|---|---|
| 2026-06-30 | $5.70M 10-Q · filed 2026-08-05 | $9.20M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $5.20M 10-Q · filed 2026-04-30 | |
| 2025-06-30 | $2.40M 10-Q · filed 2026-08-05 | $7.10M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $4.00M 10-Q · filed 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |